News News

November 22, 2021 Codex DNA and RNAimmune Announce Collaboration to Optimize Development of Future mRNA Synthesis and Delivery Kits

Agreement will allow researchers to streamline development of novel mRNA therapeutics and vaccines SAN DIEGO, CA and…

November 15, 2021 Sirnaomics to Present at TIDES Europe 2021

Sirnaomics, Inc., a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and…

September 21, 2021 Sirnaomics, Inc. to Present at TIDES USA 2021

Sirnaomics, Inc., a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and…

July 14, 2021 Sirnaomics Doses First Patient in Phase 2 Study of STP705 for Keloid Scar Prevention

Expects to Report Initial Clinical Data in Second Half of 2021  Sirnaomics, Inc., a biopharmaceutical company engaged…

July 6, 2021 Sirnaomics Receives FDA Approval of IND for Phase 1 Clinical Trial of Systemic RNAi Therapeutic STP707 for Solid Tumor Treatment

Sirnaomics, Inc., a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announces today that the…

1 2 3 12